144153-40-2

Upstream product

• 81282-38-4 N-diphenoxymethylene benzamide 
• 132553-79-8 3-(1-trityl-1H-imidazol-4-yl)prop-2-enamine 

Downstream Products

• 144153-37-7 N-Benzoyl-N'-[2-(pyridin-2-ylmethylsulfanyl)-ethyl]-N''-[(E)-3-(1-trityl-1H-imidazol-4-yl)-allyl]-guanidine 
• 144153-39-9 N-Benzoyl-N'-(3,3-diphenyl-propyl)-N''-[(E)-3-(1-trityl-1H-imidazol-4-yl)-allyl]-guanidine 
• 144284-43-5 N-(3,3-Diphenyl-propyl)-N'-[(E)-3-(1H-imidazol-4-yl)-allyl]-guanidine; compound with picric acid 
• 144284-39-9 N-[(E)-3-(1H-Imidazol-4-yl)-allyl]-N'-[2-(pyridin-2-ylmethylsulfanyl)-ethyl]-guanidine; compound with picric acid 
• 144284-41-3 N-(2-Benzylsulfanyl-ethyl)-N'-[(E)-3-(1H-imidazol-4-yl)-allyl]-guanidine; compound with picric acid 
• 144153-38-8 N-Benzoyl-N'-(2-benzylsulfanyl-ethyl)-N''-[(E)-3-(1-trityl-1H-imidazol-4-yl)-allyl]-guanidine 

Relevant academic research and scientific papers

The effect of lipophilic substituents on the H2-histaminergic activity of some close analogues of impromidine

The cimetidine-like moiety of the potent H2-agonist impromidine (9a) and three closely related guanidines (10a, 11a, and 12a) which are modified in the imidazolylpropyl portion, has been replaced by 2-[(2-pyridyl)methylthio]ethyl, 2-(benzylthio